Hamman-Rich syndrome
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| HR syndrome Classification and external resources | |
| ICD-10 | J84.1 |
|---|---|
| ICD-9 | 516.3 |
| OMIM | 178500 |
| DiseasesDB | 4815 |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Hamman-Rich syndrome (also known as acute interstitial pneumonia) is a rare, severe lung disease which usually affects otherwise healthy individuals.
HR syndrome is often categorized as both an interstitial lung disease and a form of acute respiratory distress syndrome (ARDS).
Symptoms
The most common symptoms of Hamman-Rich syndrome are cough, fever, and difficulties breathing. These often occur over a period of one to two weeks before medical attention is sought. Difficulties breathing can quickly progress to an inability to breathe without support (respiratory failure).
Hamman-Rich syndrome typically progresses rapidly, with hospitalization and mechanical ventilation often required only days to weeks after initial symptoms of cough, fever, and difficulties breathing develop.
Diagnosis
Rapid progression from initial symptoms to respiratory failure is a key feature of Hamman-Rich syndrome. An x-ray which shows ARDS is necessary for diagnosis (fluid in the small air sacs (alveoli) in both lungs). In addition, a biopsy of the lung which shows organizing diffuse alveolar damage is required for diagnosis. Other diagnostic tests are useful excluding other similar condition, but history, x-ray, and biopsy are necessary. These other tests may include basic blood work, blood cultures, and bronchoalveolar lavage.
Treatment
Treatment of HR syndrome is primarily supportive. Management in an intensive care unit is required and the need for mechanical ventilation is common. Therapy with corticosteroids is generally attempted, though their usefulness has not been established as of 2005.
Epidemiology
HR syndrome occurs most frequently among people older than forty years old. It affects men and women equally. There are no known risk factors; in particular, smoking is not associated with increased risk.
Prognosis
Sixty percent of people with HR syndrome will die in the first six months of illness. However, most people who have one episode do not have a second. People who survive often recover lung function completely.
History
HR syndrome was first described in 1935 by Louis Hamman and Arnold Rich.
References
- ^ HR, AR. Fulminating diffuse interstitial fibrosis of the lungs. Trans Am Clin Climatol Assoc 1935; 51:154.
External links
- synd/3010 at Who Named It
- 00181 at CHORUS
- 1241907254 at GPnotebook
- LUN100 at FPnotebook
WikiDoc Research Resources for Hamman-Rich syndrome | |
|---|---|
| Articles on Hamman-Rich syndrome | Most recent articles on Hamman-Rich syndrome • Most cited articles on Hamman-Rich syndrome • Review articles on Hamman-Rich syndrome • Articles on Hamman-Rich syndrome in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Hamman-Rich syndrome | Powerpoint slides on Hamman-Rich syndrome • Images of Hamman-Rich syndrome • Photos of Hamman-Rich syndrome • Podcasts & MP3s on Hamman-Rich syndrome • Videos on Hamman-Rich syndrome |
| Evidence Based Medicine Regarding Hamman-Rich syndrome | Cochrane Collaboration on Hamman-Rich syndrome • Bandolier on Hamman-Rich syndrome • TRIP on Hamman-Rich syndrome |
| Cost Effectiveness of Hamman-Rich syndrome | Cost Effectiveness of Hamman-Rich syndrome |
| Clinical Trials Involving Hamman-Rich syndrome | Ongoing Trials on Hamman-Rich syndrome at Clinical Trials.gov • Trial results on Hamman-Rich syndrome • Clinical Trials on Hamman-Rich syndrome at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Hamman-Rich syndrome | US National Guidelines Clearinghouse on Hamman-Rich syndrome • NICE Guidance on Hamman-Rich syndrome • NHS PRODIGY Guidance • FDA on Hamman-Rich syndrome • CDC on Hamman-Rich syndrome |
| Textbook Information on Hamman-Rich syndrome | Books and Textbook Information on Hamman-Rich syndrome |
| Pharmacology Resources on Hamman-Rich syndrome | Dosing of Hamman-Rich syndrome • Drug interactions with Hamman-Rich syndrome • Side effects of Hamman-Rich syndrome • Allergic reactions to Hamman-Rich syndrome • Overdose information on Hamman-Rich syndrome • Carcinogenicity information on Hamman-Rich syndrome • Hamman-Rich syndrome in pregnancy • Pharmacokinetics of Hamman-Rich syndrome • |
| Genetics, Pharmacogenomics, and Proteinomics of Hamman-Rich syndrome | Genetics of Hamman-Rich syndrome • Pharmacogenomics of Hamman-Rich syndrome • Proteomics of Hamman-Rich syndrome |
| Newstories on Hamman-Rich syndrome | Hamman-Rich syndrome in the news • Be alerted to news on Hamman-Rich syndrome • News trends on Hamman-Rich syndrome |
| Commentary on Hamman-Rich syndrome | Blogs on Hamman-Rich syndrome |
| Patient Resources on Hamman-Rich syndrome | Patient resources on Hamman-Rich syndrome • Discussion groups on Hamman-Rich syndrome • Patient Handouts on Hamman-Rich syndrome • Directions to Hospitals Treating Hamman-Rich syndrome • Risk calculators and risk factors for Hamman-Rich syndrome |
| Healthcare Provider Resources on Hamman-Rich syndrome | Symptoms of Hamman-Rich syndrome • Causes & Risk Factors for Hamman-Rich syndrome • Diagnostic studies for Hamman-Rich syndrome • Treatment of Hamman-Rich syndrome |
| Continuing Medical Education (CME) Programs on Hamman-Rich syndrome | CME Programs on Hamman-Rich syndrome |
| International Resources on Hamman-Rich syndrome | Hamman-Rich syndrome en Espanol • Hamman-Rich syndrome en Francais |
| Business Resources on Hamman-Rich syndrome | Hamman-Rich syndrome in the Marketplace • Patents on Hamman-Rich syndrome |
| Informatics Resources on Hamman-Rich syndrome | List of terms related to Hamman-Rich syndrome |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

